Skip To Main Content
Anita Barta on Muck Rack

Anita Barta

As seen in: Wiley Online Library, MDPI, ACS Publications
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Anita

Contact Anita, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Unveiling the Anticancer Potential of Verbascum aydogdui: Isolation, Characterization, and In Vitro Studies

|
By Anita Barta, Başak Aru, Şerife Sena Günaydın, Ayşe Nur Çaldıran
| Wiley Online Library Verified
Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The authors have nothing to report.
Open in Who Shared Issue with article?

Euphane and Tirucallane Triterpenes with Trypanocidal Activity from Euphorbia desmondii

|
By Muhammad Bello Saidu, Gordana Krstić, Anita Barta, Attila Hunyadi
| dx.doi.org
Trypanosoma cruzi, a parasitic protozoan, is the causative agent of Chagas disease (American trypanosomiasis). It is believed that 6–7 million people worldwide, primarily in Latin America, suffer from this disease, which accounts for 12,000 fatalities annually. Further, 10% of patients with persistent infections experience neurological or digestive disorders or both, and up to one-third of these patients experience cardiac changes that may require special care.
Open in Who Shared Issue with article?

Euphane and Tirucallane Triterpenes with Trypanocidal Activity from Euphorbia desmondii

|
By Muhammad Bello Saidu, Gordana Krstić, Anita Barta, Attila Hunyadi
| ACS Publications
Trypanosoma cruzi, a parasitic protozoan, is the causative agent of Chagas disease (American trypanosomiasis). It is believed that 6–7 million people worldwide, primarily in Latin America, suffer from this disease, which accounts for 12,000 fatalities annually. Further, 10% of patients with persistent infections experience neurological or digestive disorders or both, and up to one-third of these patients experience cardiac changes that may require special care.
Open in Who Shared Issue with article?
See all 5 articles